Roswell Park Comprehensive Cancer Center — Buffalo, New York

Public research footprint of Roswell Park Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

164

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B Cell Lymphoma (DLBCL) · Non-Hodgkin Lymphoma · Chronic Myeloid Leukemia, Chronic Phase · NSCLC (Non-small Cell Lung Cancer)

Recently updated registry entries

NCT06852222 — A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… (Recruiting)
NCT04811560 — A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) (Recruiting)
NCT07679334 — Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Roswell Park Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.